MIR210HG is elevated in a variety of tumors such as cervical cancer, non-small cell lung cancer, breast cancer, colorectal adenocarcinoma, pancreatic cancer, liver cancer, osteosarcoma, and glioma (Min et al., 2016; Li et al., 2017; Li et al., 2019; Wang et al., 2019; Ai-Hong Wang et al., 2020). Here, MIR210HG is linked to breast cancer.